Vytrus Biotech S.A. Cash Flow Reinvestment Rate
Vytrus Biotech S.A. cash flow reinvestment rate. Vytrus Biotech S.A. (VYT) has a Cash Flow Reinvestment Rate of 2.19x as of December 2022, reinvesting €494.16K (capex €494.16K ) from operating cash flow of €225.55K. Explore Vytrus Biotech S.A. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Vytrus Biotech S.A. (2021–2025)
Cash flow reinvestment rate of Vytrus Biotech S.A. from 2021 to 2025. Historical reinvestment intensity for Vytrus Biotech S.A. across 5 annual periods. Explore Vytrus Biotech S.A. capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Vytrus Biotech S.A. Cash Flow Reinvestment Rate by Year (2021–2025)
Vytrus Biotech S.A. cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for Vytrus Biotech S.A.. For the full cash flow conversion analysis, see how efficiently does Vytrus Biotech S.A. generate cash.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.71x | €2.76 Million | €3.90 Million | €2.68 Million | ▲ +8.1% |
| 2024 | 0.65x | €1.21 Million | €1.84 Million | €1.20 Million | ▼ -49.9% |
| 2023 | 1.31x | €1.18 Million | €904.39K | €1.17 Million | ▼ -44.0% |
| 2022 | 2.33x | €526.44K | €225.55K | €494.16K | ▲ +245.3% |
| 2021 | 0.68x | €302.78K | €447.92K | €271.82K | — |